Evidence Synthesis
APEX has accelerated its 39.11% gross margin to a quarterly high, up from 10.16%.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 18 Sept 2026, 00:11
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
APEX has accelerated its 39.11% gross margin to a quarterly high, up from 10.16%.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 39.11 % | 10.16 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 10.16 % | 5.53 | ▲ |
| REVENUE_GROWTH_YOY | -0.6 % | 138.1 | ▼ |
| PRICE_CHANGE_PERCENT | 0.862 % | — | - |
| DAILY_VOLUME | 49,573 shares | 3,10,143 | ▼ |
| CLOSE_PRICE | 350.95 INR | 347.95 | ▲ |